ClinVar Miner

Submissions for variant NM_000138.5(FBN1):c.6834C>T (p.Pro2278=)

gnomAD frequency: 0.00006  dbSNP: rs397515839
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000035255 SCV000058902 likely benign not specified 2011-12-30 criteria provided, single submitter clinical testing Pro2278Pro variant in exon 55 of FBN1: This variant is not expected to have clin ical significance because it does not alter an amino acid residue, is not locate d within the splice consensus sequence, and it has been identified in 0.014% (1/ 7020) of European American chromosomes by the NHBLI Exome sequencing project in a clinical cohort that included individuals with heart disease (http://evs.gs.wa shington.edu/EVS, rs148250409).
GeneDx RCV001703453 SCV000516736 likely benign not provided 2021-02-03 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000470181 SCV000557022 likely benign Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection 2024-01-17 criteria provided, single submitter clinical testing
Ambry Genetics RCV000769625 SCV000738800 likely benign Familial thoracic aortic aneurysm and aortic dissection 2017-10-20 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV000769625 SCV000901022 likely benign Familial thoracic aortic aneurysm and aortic dissection 2016-08-05 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000769625 SCV000904641 likely benign Familial thoracic aortic aneurysm and aortic dissection 2018-07-15 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000035255 SCV003800651 benign not specified 2023-01-14 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV003996192 SCV004822426 likely benign Marfan syndrome 2024-02-05 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004528167 SCV000302581 likely benign FBN1-related disorder 2024-01-29 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.